Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Samassekou, Oumar ^a   Malina, Abba ^b   Hébert, Josée ^c   Yan, Ju ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Cancer biology; CML; Telomeres

Indexed keywords

TELOMERASE;

ARTICLE; CHROMOSOME; CHRONIC MYELOID LEUKEMIA; CIRCULAR EXTRACHROMOSOME TELOMERE REPEAT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; LEUKEMIA CELL; TELOMERE; TELOMERE HOMEOSTASIS;

CHROMOSOME ABERRATIONS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; REAL-TIME POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TUMOR CELLS, CULTURED;

EID: 84875550466     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-26     Document Type: Article

References (24)

1. Telomeres: beginning to understand the end. Zakian VA, Science 1995 270 1601 1607 10.1126/science.270.5242.1601 7502069
2. DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Henson JD, Cao Y, Huschtscha LI, Chang AC, Au AY, Pickett HA, Reddel RR, Nat Biotechnol 2009 27 1181 1185 10.1038/nbt.1587 19935656
3. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR, Nat Med 1997 3 1271 1274 10.1038/nm1197-1271 9359704
4. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR, Cancer Res 1999 59 4175 4179 10485449
5. Telomere uncapping and alternative lengthening of telomeres. Cesare AJ, Reddel RR, Mech Ageing Dev 2008 129 99 108 10.1016/j.mad.2007.11.006 18215414
6. Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells. Nabetani A, Ishikawa F, J Biochem 2011 149 5 14 10.1093/jb/mvq119 20937668
7. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Cesare AJ, Griffith JD, Mol Cell Biol 2004 24 9948 9957 10.1128/MCB.24.22.9948-9957.2004 15509797
8. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Fasching CL, Neumann AA, Muntoni A, Yeager TR, Reddel RR, Cancer Res 2007 67 7072 7077 10.1158/0008-5472.CAN-07-1556 17652140
9. Control of telomere length by a trimming mechanism that involves generation of t-circles. Pickett HA, Cesare AJ, Johnston RL, Neumann AA, Reddel RR, EMBO J 2009 28 799 809 10.1038/emboj.2009.42 19214183
10. Homologous recombination generates T-loop-sized deletions at human telomeres. Wang RC, Smogorzewska A, de Lange T, Cell 2004 119 355 10.1016/j.cell.2004.10.011 15507207
11. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR, Nature 1982 300 765 767 10.1038/300765a0 6960256
12. Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia. Drummond M, Lennard A, Brummendorf T, Holyoake T, Leuk Lymphoma 2004 45 1775 1781 10.1080/10428190410001693542 15223635
13. Telomeres and telomerase in hematologic neoplasia. Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K, Oncogene 2002 21 680 687 10.1038/sj.onc.1205075 11850796
14. Individual telomere lengths in chronic myeloid leukemia. Samassekou O, Ntwari A, Hebert J, Yan J, Neoplasia 2009 11 1146 1154 19881950
15. Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Tokutake Y, Matsumoto T, Watanabe T, Maeda S, Tahara H, Sakamoto S, Niida H, Sugimoto M, Ide T, Furuichi Y, Biochem Biophys Res Commun 1998 247 765 772 10.1006/bbrc.1998.8876 9647768
16. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Costa A, Daidone MG, Daprai L, Villa R, Cantu S, Pilotti S, Mariani L, Gronchi A, Henson JD, Reddel RR, Zaffaroni N, Cancer Res 2006 66 8918 8924 10.1158/0008-5472.CAN-06-0273 16951210
17. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Villa R, Daidone MG, Motta R, Venturini L, De Marco C, Vannelli A, Kusamura S, Baratti D, Deraco M, Costa A, Clin Cancer Res 2008 14 4134 4140 10.1158/1078-0432.CCR-08- 0099 18593991
18. Short telomeres initiate telomere recombination in primary and tumor cells. Morrish TA, Greider CW, PLoS Genet 2009 5 1000357 10.1371/journal.pgen. 1000357 19180191
19. Detection of alternative lengthening of telomeres by telomere quantitative PCR. Lau LM, Dagg RA, Henson JD, Au AY, Royds JA, Reddel RR, Nucleic Acids Res 2013 41 34 10.1093/nar/gks781 22923525
20. Alternative lengthening of telomeres in normal mammalian somatic cells. Neumann AA, Watson CM, Noble JR, Pickett HA, Tam PP, Reddel RR, Genes Dev 2013 27 18 23 10.1101/gad.205062.112 23307865
21. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Cerone MA, Autexier C, Londono-Vallejo JA, Bacchetti S, Oncogene 2005 24 7893 7901 10.1038/sj.onc.1208934 16116482
22. Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Chen Q, Ijpma A, Greider CW, Mol Cell Biol 2001 21 1819 1827 10.1128/MCB.21.5.1819-1827.2001 11238918
23. Chromosome-arm-specific long telomeres: a new clonal event in primary chronic myelogenous leukemia cells. Samassekou O, Li H, Hébert J, Ntwari A, Wang H, Cliche CG, Bouchard E, Huang S, Yan J, Neoplasia 2011 13 550 560 21677878
24. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K, Leukemia 1997 11 190 194 10.1038/sj.leu.2400560 9009079